Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc.

Bullboard Posts

Post by Rishikon Sep 25, 2017 9:04pm

321 Views

Post# 26740495

Conference calls, Updates on PBI, Ryplazim, about time

We get what we are all waiting for:
a DEAL
or
FDA approval of Ryplazim.

i dont see what else they could announce in the near future excepted these 2 we are patiently waiting for.

Any guess on what could be next. Other news that wont impact SP or a fu kn SP hitter?

Bullboard Posts

Three micro-cap value stocks trading at peak pessimism